My notes from the Confrenece Call:
- SI to discuss if the trial can be funded by academic institutions. Invetory for the trial is ready with the company, no more expense required.
- If this trial is successful, approval to come for both Padeatric as well as Adults.
- It's going to be an easier and shorter trial as patients are easy to enrol due to no other therapy available.
- Duration of Trial, Number of Patients required for trial and if the Trial will be RCT (with or without control arm) will be decided after FDA meeting.
- EAP continuation to be discussed and confirmed in meeting with FDA
SI dodged one critical question by John Hester: He just didn't answer that and asked for disconnection of lines and wrap-up of conference.
- Company's financial situation and plans to manage funds with short runway left with existing funds.
Overall, IMO, it's a thunderstorm in near term, more dilution, but not all over yet, it's not a step forward, not well timed though.
There is still hope and better hope than what it was 6 months ago.
- Forums
- ASX - By Stock
- Ann: Update on BLA for Graft Versus Host Disease
My notes from the Confrenece Call:- SI to discuss if the trial...
- There are more pages in this discussion • 817 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.13 |
Change
0.040(3.67%) |
Mkt cap ! $1.284B |
Open | High | Low | Value | Volume |
$1.10 | $1.14 | $1.08 | $5.374M | 4.841M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
18 | 120649 | $1.13 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.14 | 41920 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 136364 | 1.130 |
14 | 59494 | 1.125 |
15 | 298774 | 1.120 |
9 | 86457 | 1.115 |
6 | 29314 | 1.110 |
Price($) | Vol. | No. |
---|---|---|
1.135 | 40707 | 5 |
1.140 | 209510 | 18 |
1.145 | 239980 | 11 |
1.150 | 373854 | 17 |
1.155 | 47000 | 3 |
Last trade - 14.30pm 18/06/2024 (20 minute delay) ? |
|
|||||
Last
$1.13 |
  |
Change
0.040 ( 4.06 %) |
|||
Open | High | Low | Volume | ||
$1.10 | $1.14 | $1.08 | 1069443 | ||
Last updated 14.51pm 18/06/2024 ? |
Featured News
MSB (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O'Donovan, Executive Director
Gerard O'Donovan
Executive Director
SPONSORED BY The Market Online